Related Experiment Video
Updated: Mar 13, 2026

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
Published on: September 26, 2025
Medical regulation of cognitive enhancement devices: some concerns
Mike King1, Colin Gavaghan2, John McMillan3
1Lecturer, Bioethics Centre, University of Otago, Dunedin.
Abstract:
The authors present a cogent and detailed case for altering the Medical Devices Directive to allow regulation of cognitive enhancement devices (CEDs). Protection against significant risk of harm, especially for the vulnerable, and promotion of benefit through informed use of CEDs are all good features of the proposal. However, the pre-market approval process has limitations, which we explore. We raise the possibility of 'risk compensation' in response to the introduction of safety measures, which could alter its effectiveness. The proposal alludes to use of 'formally trained practitioners,' which provide a further tier of regulation for CEDs within the proposal. We consider some positive and negative implications of this aspect of the proposal that might warrant further consideration.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
CNS Stimulants: Psychedelic Agents

